Clinical Trial Update: Hemophilia Inhibitor Genetics Study (HIGS)

View source ↗

Summary

The Hemophilia Inhibitor Genetics Study (HIGS) clinical trial has completed, per sponsor Skane University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Skane University Hospital | Conditions: Hemophilia A With Inhibitor | Status: COMPLETED